Email Alerts
Tonix Pharmaceuticals trades on the OTCQB under the symbol TNXP
TONIX Pharmaceuticals
Home
Company Info
Overview
Management Team
Board of Directors
Scientific Advisory Board
Products
TNX-102 SL for Fibromyalgia
TNX-102 SL for PTSD
Therapeutics Areas
Overview
Fibromyalgia Syndrome
Post-traumatic Stress Disorder
Media Center
Press Releases
TONIX In The News
Presentations
Investor Relations
Overview
News / Events
Press Releases
TONIX In The News
IR Events
Presentations
Letters To Shareholders
Email Alerts
Company Information
Profile
Management Team
Contacts
FAQ
Financial Information
Financials
Conference Calls
Stock Information
Quote
Charts
Historical Quotes
SEC Filings
All SEC Filings
Section 16
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
TONIX In The News
Media Center
Press Releases
TONIX In The News
Presentations
Home
Media Center
TONIX In The News
Refreshing Sleep Erases Fibromyalgia Pain
May 6, 2013
Replenishing Pipelines By Repurposing and Rescuing Pharmaceuticals
May 1, 2013
Muscle Relaxant To Treat PTSD Sleep Problems?
Apr 18, 2013
Treating fibromyalgia with a good night’s sleep
Feb 5, 2013
Repurposing Drugs
Jan 30, 2013
Tonix Pharmaceuticals (TNXP): A Low-Risk Biotech With Near-Term Catalysts
Oct 29, 2012
Tonix Pharmaceuticals Holding Corp. (TNXP) Pushes to Join Ranks of Heavyweight Counterparts with a Different Spin on Fibromyalgia Treatment
Oct 26, 2012
Tonix: A Small Biotech With The Potentially Huge Key To The Fibromyalgia Puzzle
Oct 25, 2012
CEONEWS.Tv Executive Spotlight - TONIX Pharmaceuticals Holding Corp. - Dr. Leland Gershell - (TNXP)
Oct 1, 2012
CEONEWS.Tv Executive Spotlight - TONIX Pharmaceuticals Holding Corp. - Dr. Seth Lederman - (TNXP)
Sep 19, 2012
TONIX to Choose CRO by Mid-October for Phase III Fibromyalgia Stufy with TNX-102 - CEO
Sep 12, 2012
Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals
Aug 29, 2012
Interview with Dr. Seth Lederman: Easing the Pain and Suffering of Fibromyalgia
Aug 28, 2012
Kidela interviews: Tonix Pharmaceuticals
Aug 17, 2012
CEOLIVE Investor Insight Interview featuring Dr. Seth Lederman, CEO
Aug 15, 2012
CDTV Interview with Seth Lederman, CEO
Aug 6, 2012
Tonix Pharmaceuticals CEO Seth LedermanTalks Importance of Fibromyalgia
Jun 12, 2012
A Passion for Tough Medical Problems
Jun 1, 2012
TONIX CEO Seth Lederman, MD, interviewed on CEOLive.TV
May 21, 2012
Tonix Pharmaceuticals Holding Corp. is Focused on Developing Innovative Drugs that Address Central Nervous System (CNS) Conditions
Apr 9, 2012
Tonix Pharmaceuticals Completes $4.3 Private Placement Funding
Feb 7, 2012
The Promise of TNX-102 in Fibromyalgia Syndrome
Nov 1, 2011
Tonix Pharmaceuticals completes reverse merger
Oct 17, 2011
Muscle Relaxant May Ease Fibromyalgia Pain Low Doses of Cyclobenzaprine Improved Sleep, Pain in Small Study
Sep 14, 2011
Clinical Results
Sep 12, 2011
TONIX Pharmaceuticals has highlighted upbeat Phase IIa data on the use of low doses of cyclobenzaprine...
Sep 9, 2011
TONIX Advances in Nighttime Fibromyalgia Meds Released
Sep 7, 2011